Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Platelet-rich plasma may improve embryo genetics in IVF.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The combined therapy improved symptoms in PCOS patients.

Melatonin may help treat PCOS symptoms in rats.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

PCOS causes hormonal issues and infertility, with treatment options including medication and lifestyle changes.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Early diagnosis and treatment of endocrine disorders like HAIR-AN syndrome can improve outcomes in adolescents.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Fat cells in the skin help start healing and form important repair cells after injury.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.